Clearpoint Neuro Stock Analysis

Clearpoint Stock Analysis Notes

About 42.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.8. Clearpoint Neuro last dividend was issued on the 27th of July 2016. The entity had 1:40 split on the 27th of July 2016. ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California. Clearpoint Neuro operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 80 people. For more info on Clearpoint Neuro please contact Joseph Burnett at 888 287 9109 or go to https://www.clearpointneuro.com.

Clearpoint Neuro Investment Alerts

Clearpoint Largest EPS Surprises

View All Earnings Estimates

Clearpoint Neuro Environmental, Social, and Governance (ESG) Scores

Clearpoint Stock Institutional Investors

Note, although Clearpoint Neuro's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Clearpoint Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 404.28 M.

Clearpoint Profitablity

The company has Profit Margin (PM) of (0.67) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.6) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.6.

Management Efficiency

Clearpoint Neuro has return on total asset (ROA) of (0.283) % which means that it has lost $0.283 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0313) %, meaning that it created substantial loss on money invested by shareholders. Clearpoint Neuro's management efficiency ratios could be used to measure how well Clearpoint Neuro manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.46 in 2026. Return On Capital Employed is likely to drop to -0.83 in 2026. At this time, Clearpoint Neuro's Non Current Liabilities Other is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 1.9 M in 2026, whereas Total Current Liabilities is likely to drop slightly above 5 M in 2026.

Technical Drivers

As of the 11th of February 2026, Clearpoint Neuro shows the risk adjusted performance of (0.03), and Mean Deviation of 3.56. Clearpoint Neuro technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Clearpoint Neuro Price Movement Analysis

Clearpoint Neuro Insider Trading Activities

Clearpoint Neuro Outstanding Bonds

Clearpoint Neuro Predictive Daily Indicators

Clearpoint Neuro Corporate Filings

Clearpoint Neuro Forecast Models

Clearpoint Neuro's time-series forecasting models are one of many Clearpoint Neuro's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Clearpoint Neuro's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Clearpoint Neuro Bond Ratings

Clearpoint Neuro financial ratings play a critical role in determining how much Clearpoint Neuro have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Clearpoint Neuro's borrowing costs.

Clearpoint Neuro Debt to Cash Allocation

Clearpoint Neuro currently holds 3.57 M in liabilities with Debt to Equity (D/E) ratio of 0.28, which may suggest the company is not taking enough advantage from borrowing. Clearpoint Neuro has a current ratio of 10.12, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Clearpoint Neuro's use of debt, we should always consider it together with its cash and equity.

Clearpoint Neuro Common Stock Shares Outstanding Over Time

Clearpoint Neuro Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Clearpoint Neuro uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Clearpoint Neuro Debt Ratio

9.95

It appears most of the Clearpoint Neuro's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Clearpoint Neuro's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Clearpoint Neuro, which in turn will lower the firm's financial flexibility.

Clearpoint Neuro Corporate Bonds Issued

Clearpoint Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Clearpoint Neuro prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Clearpoint shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Clearpoint Neuro. By using and applying Clearpoint Stock analysis, traders can create a robust methodology for identifying Clearpoint entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Clearpoint analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Clearpoint analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Clearpoint Neuro stock analysis indicators help investors evaluate how Clearpoint Neuro stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Clearpoint Neuro shares will generate the highest return on investment. By understating and applying Clearpoint Neuro stock analysis, traders can identify Clearpoint Neuro position entry and exit signals to maximize returns.

When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.